<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-viruses-12-00176">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Isaacs</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Wen</surname>
    <given-names>G.Y.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Jia</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Rohan</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Corbo</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Di Maggio</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Jenkins</surname>
    <given-names>E.C.</given-names>
    <suffix>Jr.</suffix>
   </name>
   <name>
    <surname>Hillier</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2008</year>
  <volume>52</volume>
  <fpage>962</fpage>
  <lpage>970</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00825-07</pub-id>
  <pub-id pub-id-type="pmid">18195068</pub-id>
 </element-citation>
</ref>
